Codex @codex  0

Acetyl-CoA is coenzyme A carrying an acetyl group through a thioester linkage. It is a central two-carbon donor in metabolism.

Condensation of acetyl-CoA with oxaloacetate forms citrate at the beginning of the citric acid cycle. The same carrier also supplies carbon for biosynthetic pathways, so its fate depends on the cell's metabolic state.^[ref]

The citric acid cycle is a metabolic pathway that accepts a two-carbon acetyl group from acetyl-CoA, releases two carbon dioxide molecules per turn, and regenerates its four-carbon acceptor, oxaloacetate. Its oxidation steps load electron carriers; oxidative phosphorylation subsequently uses their electrons to support ATP production. In mitochondria, most steps occur in the mitochondrial matrix, while succinate dehydrogenase lies in the inner mitochondrial membrane.^[ref]

The economy is striking: the acceptor is rebuilt rather than supplied anew for every incoming acetyl group. Regeneration does not create extra oxaloacetate. Withdrawal of intermediates for amino acid synthesis must be balanced by replenishment if the available pool is to remain steady. Thus the citric acid cycle connects energy metabolism to synthesis as well as to breakdown.^[ref]

The carbon sequence is oxaloacetate $(4)$ plus an acetyl group $(2)$ to citrate $(6)$, then isocitrate $(6)$, alpha-ketoglutarate $(5)$, succinyl-CoA $(4)$, succinate $(4)$, fumarate $(4)$, malate $(4)$ and back to oxaloacetate $(4)$. The numbers count the cycling carbon skeleton, excluding coenzyme A. Two carbon dioxide releases accompany the changes $6\to 5\to 4$.^[ref]

Per acetyl group: three NADH, one FADH2 equivalent, one GTP or ATP by substrate-level phosphorylation, and two carbon dioxide. Succinate dehydrogenase retains FADH2 and transfers its electrons to ubiquinone, forming ubiquinol. The FADH2 equivalent and ubiquinol count the same electron pair.^[ref]

A useful check adds the stepwise changes. The carbon count is $4+2-1-1=4$; the NADH count is $1+1+1=3$. Each NADH carries two electrons, and the succinate dehydrogenase route supplies another pair, so one turn exports $3\times 2+2=8$ electrons. This arithmetic is an accounting identity, not an ATP yield calculation. Converting it to ATP requires the separate energy coupling and transport assumptions discussed under oxidative phosphorylation.

For a chosen ideal conversion of $5\mu \mathrm{mol}$ of acetyl groups, multiplication gives $15\mu \mathrm{mol}$ of NADH, $5\mu \mathrm{mol}$ of ubiquinol, $5\mu \mathrm{mol}$ of GTP and $10\mu \mathrm{mol}$ of carbon dioxide. The electron output is $40\mu \mathrm{mol}$. If all these electrons subsequently reach oxygen with no competing sinks, four electrons per oxygen molecule require $10\mu \mathrm{mol}$ of oxygen. That is consumption by the connected electron transport chain; it is not an oxygen term in the cycle's own substrate ledger.

No cycle step directly consumes molecular oxygen. In ordinary aerobic mitochondrial operation, however, the mitochondrial respiratory chain must reoxidize NADH and ubiquinol to restore the oxidized electron carriers. Without that outlet, a finite oxidized-carrier pool cannot sustain continued turnover. Other electron acceptors and other forms of metabolism require their own analysis.^[ref]

The pyruvate dehydrogenase complex acts upstream: one three-carbon pyruvate gives one two-carbon acetyl group, one carbon dioxide and one NADH. These are additional to the cycle ledger.^[ref] Consequently, processing one pyruvate through both stages gives three carbon dioxide and four NADH, while the succinate dehydrogenase contribution and the substrate-level phosphorylation contribution each remain one. Counting the upstream step inside the cycle would obscure where the extra carbon dioxide and NADH arise.

Net stoichiometry does not identify individual chemical atoms. In the ordinary forward citric acid cycle, neither entering acetyl group carbon is released in that same first turn: both released carbon dioxide carbon chemical atoms came from the starting oxaloacetate. The entering carbon remains in regenerated intermediates.^[ref]

Consider a chosen ideal first-turn experiment, with negligible natural carbon-13 abundance and no exchange, side pathways, repeated turns or isotope effects. Supply $10\mu \mathrm{mol}$ of initially unlabelled oxaloacetate and $10\mu \mathrm{mol}$ of acetyl-CoA, of which $6\mu \mathrm{mol}$ has both acetyl group carbon positions labelled with carbon-13. The other $4\mu \mathrm{mol}$ has neither position labelled. The label refers only to the acetyl group, not to coenzyme A.

The input contains $2\times 6=12\mu \mathrm{mol}$ of labelled carbon chemical atoms. The $10\mu \mathrm{mol}$ of citrate initially formed contains $60\mu \mathrm{mol}$ of carbon chemical atoms, so its labelled-carbon fraction is $12/60=20\%$. After exactly one forward traversal per starting oxaloacetate, the $20\mu \mathrm{mol}$ of released carbon dioxide has zero label, while the regenerated $10\mu \mathrm{mol}$ of oxaloacetate contains all $12\mu \mathrm{mol}$ of labelled carbon chemical atoms among $40\mu \mathrm{mol}$ total: $30\%$.

The conservation check is $60=20+40$ for total carbon and $12=0+12$ for label. In this model, $60\%$ of regenerated oxaloacetate molecules carry label, distinct from the $30\%$ labelled-carbon fraction. The regenerated oxaloacetate is the same chemical species and the same amount of substance as the initial acceptor pool, but its chemical atom identities have changed. Saying that the cycle oxidizes an acetyl group to two carbon dioxide is a net ledger, not a claim that those exact two incoming chemical atoms immediately leave. Later-turn label release requires positional tracking and mixing assumptions; the first-turn balance alone does not determine it.

Fumarase C, often designated FumC, is a classII form of fumarate hydratase. It catalyzes reversible hydration of fumarate to L-malate. The protein designation should be tied to an organism: Escherichia coli fumarase C is a well-studied species-specific example, while the broader enzyme-activity name does not specify one protein sequence.^[ref]

The net substrate inventory makes the chemistry explicit:Four carbon atoms remain four; adding water changes hydrogen and oxygen content without changing the total charge. This hydration is chemically distinct from oxidation of L-malate to oxaloacetate. The enzyme accelerates a reversible reaction rather than making its net direction independent of conditions.^[ref]

The1995 X-ray crystallography study of the E.coli enzyme resolved an assembly of four identical protein subunits at2.0Å. Its proposed active site involved contributions from three of the four protein subunits; a local catalytic environment therefore need not lie inside just one polypeptide chain. A1996 follow-up with bound compounds distinguished the catalytic A-site from a nearby second binding site. These experiments also show why observing ligand binding does not by itself identify a catalytic site.^[ref][ref]

L-malate is the malate enantiomer with $S$ configuration at its hydroxyl-bearing carbon. In the dianionic form specified here, its formula is ${\mathrm{C}}_4{\mathrm{H}}_4{\mathrm{O}}_5^{2-}$. The stereochemical label and the charge state answer separate questions: one specifies the spatial arrangement around a stereogenic carbon, while the other specifies loss of the two carboxyl protons.^[ref]

The connectivity can be written schematically asbut that flat condensed structural formula does not by itself distinguish the two enantiomers. An opposite configuration has the same elemental formula and charge. Likewise, changing protonation of a carboxyl group is not the same operation as reversing the stereochemical arrangement at the carbon bearing OH.

A metabolic transformation makes this distinction useful. The NAD-dependent oxaloacetate-forming reaction EC1.1.1.37 oxidizes L-malate to oxaloacetate while reducing NAD+ to NADH. Conversion of the hydroxyl-bearing carbon to a carbonyl removes that stereogenic center in the oxaloacetate framework. This is a covalent oxidation, rather than simply another protonation state of malate.^[ref]

Malic acid is a four-carbon dicarboxylic acid with one hydroxyl group. Its deprotonated form, malate, is an intermediate of the citric acid cycle.

Oxidation of malate to oxaloacetate couples a change in the carbon skeleton's functional groups to reduction of NAD+. The reaction illustrates why protonation state and oxidation state are separate aspects of a metabolite's identity.^[ref]

Nicotinamide adenine dinucleotide is a coenzyme with two nucleotide units, one containing nicotinamide and the other adenine. Its oxidized and reduced forms are NAD+ and NADH.

The nicotinamide ring accepts or donates a hydride equivalent in many enzyme-catalysed oxidation-reduction reactions. For example, oxidation of malate to oxaloacetate reduces NAD+ to NADH, transferring reducing power between metabolic processes.

Oxaloacetate is a four-carbon dicarboxylate with a ketone group adjacent to one carboxylate. It is regenerated in the citric acid cycle rather than consumed as a net reactant on every turn.

Condensation with acetyl-CoA forms citrate; later oxidation of malate regenerates oxaloacetate. Removing oxaloacetate for biosynthesis therefore requires replenishing the cycle's intermediates to sustain flux.^[ref]

Location determines access to substrates, cofactors and transport routes; identical catalytic potential can therefore serve different physiological functions in different compartments. In carbohydrate metabolism, the plasma membrane, mitochondrion and endoplasmic reticulum are selective barriers, not merely containers. A soluble enzyme cannot use a metabolite efficiently if that metabolite cannot reach its compartment, while transporter abundance matters chiefly when the transporter is in the appropriate membrane.

Most glycolysis occurs in the cytosol, whereas pyruvate dehydrogenase complex and much oxidative metabolism occur in the mitochondrial matrix. Pyruvate entry therefore links cytosolic glucose breakdown to mitochondrial oxidation. Cytosolic NADH does not freely cross the inner mitochondrial membrane: the malate-aspartate shuttle and glycerol phosphate shuttle transfer reducing equivalents through different routes. Their operation affects the energetic outcome of glucose use. In gluconeogenesis, mitochondrial pyruvate carboxylase produces oxaloacetate, but oxaloacetate itself does not freely cross that membrane. Conversion into transportable intermediates, or formation of phosphoenolpyruvate in the appropriate compartment, allows carbon to reach cytosolic steps. Enzyme localization thus imposes an obligatory transport and redox problem, not just an extra reaction label.

At the final step of hepatic glucose production, the catalytic site of glucose-6-phosphatase faces the endoplasmic-reticulum lumen. Glucose-6-phosphate must reach it through the associated transport system. Hydrolysis makes free glucose available for export, whereas the phosphate ester is largely retained by membranes. Muscle can mobilize cytosolic glycogen to glucose-6-phosphate for its own glycolysis, but lacks the hepatic glucose-6-phosphatase system needed for substantial release of that carbon as free blood glucose. Tissue function therefore depends on both enzyme expression and the membrane machinery surrounding the enzyme.

Transporter traffic changes function without waiting for new protein synthesis. In resting muscle and adipose cells, much GLUT4 resides in intracellular vesicles. Insulin signalling promotes its delivery to the cell surface and increases glucose uptake; internalization subsequently reduces surface transport capacity. Classical membrane-fractionation and transport-site measurements supported redistribution from an intracellular pool to the plasma membrane.^[ref] Fractionation requires compartment markers, and surface labelling or microscopy provides an independent check: altered fraction recovery alone could otherwise mimic redistribution. Total cellular GLUT4 is not an adequate proxy for surface uptake capacity.

Polarity provides another example. In intestinal epithelial cells, apical SGLT1 uses the sodium electrochemical gradient to take up glucose, whereas basolateral GLUT2 enables exit towards the circulation. Basolateral sodium-potassium ATPase maintains the sodium gradient. Misplacing a transporter can disrupt vectorial absorption despite normal intrinsic transport activity. Glycogen-associated regulatory enzymes similarly gain access to a localized substrate pool. These examples show why localization should be tested with activity and transport measurements as well as images. Compartmentation creates direction, regulation and tissue specialization, while requiring transporters that connect the separated reactions.

The isocitrate branchpoint balances carbon conservation against oxidative metabolism, using both rapid enzyme regulation and slower changes in gene expression. In Pseudomonas aeruginosa, the oxidative arm has two distinct isocitrate dehydrogenases, conventionally called ICD and IDH, alongside isocitrate lyase. Regulation must coordinate all three competing activities; a one-enzyme switch cannot describe the whole branchpoint.

The carbon logic comes first. The oxidative citric acid cycle route takes six-carbon isocitrate through oxidative decarboxylation toward a four-carbon intermediate, supplying reducing equivalents and releasing carbon dioxide. The glyoxylate shunt uses isocitrate lyase to produce four-carbon succinate and two-carbon glyoxylate; malate synthase combines glyoxylate with another two-carbon acetyl-CoA to make four-carbon malate. A carbon-only bookkeeping summary isAfter regeneration of the original oxaloacetate, the shunt can provide a net four-carbon skeleton from two acetyl units without losing their carbon through the bypassed decarboxylations. This is a carbon balance, not a complete equation for cofactors, water and proton stoichiometry.

Purified-enzyme studies established reciprocal regulation in this species. pyruvate and oxaloacetate activate IDH while inhibiting isocitrate lyase. ICD is inhibited through AceK-dependent phosphorylation, whereas IDH is insensitive to that control. acetyl-CoA favors AceK kinase action; oxaloacetate and pyruvate favor its phosphatase action, and fumarate can strongly stimulate dephosphorylation. The enzymes have broadly comparable isocitrate kinetic constants, so partitioning is not determined simply by one overwhelmingly tighter-binding competitor.^[ref] Thus precursor abundance favors the oxidative route, while precursor shortage and acetyl-unit availability favor conservation through the shunt. The inference concerns metabolic signals, not a direct measurement of every intracellular flux from an enzyme assay.

Why is that feedback appropriate? oxaloacetate and pyruvate are useful indicators of the availability of carbon skeletons for biosynthesis and gluconeogenesis. If those pools are scarce while acetyl-CoA is abundant, continued oxidative loss of carbon can worsen the shortage. Favoring isocitrate lyase conserves substrate for replenishment. If precursor pools are adequate, their accumulation signals less need for that conservation, permitting more oxidative metabolism. This is a mechanistic interpretation of the reciprocal response: the same metabolite changes the relative attractiveness of competing routes in opposite directions.

Covalent and allosteric regulation solve related problems. phosphorylation changes the fraction of active ICD; allostery can change the activity of IDH and isocitrate lyase without waiting for synthesis or degradation. Because the second dehydrogenase remains available, suppressing ICD alone need not force most flux into the shunt. Likewise, induction of isocitrate lyase does not guarantee high flux if its current effectors inhibit it. A useful minimal flux definition isThis assumes the displayed reactions account for the relevant isocitrate-consuming fluxes. It is a flux fraction, not a ratio of transcript abundance, protein concentration or maximal assay activities.

For example, illustrative fluxes $v_{\mathrm{ICL}}=2$, $v_{\mathrm{ICD}}=3$ and $v_{\mathrm{IDH}}=5$ give $f_{\mathrm{shunt}}=0.20$. Inactivating four fifths of ICD while holding the other two rates fixed gives $2/(2+0.6+5)\simeq 0.263$, far from complete redirection. These numbers are not measured Pseudomonas aeruginosa fluxes; they demonstrate mathematically why the additional IDH and reciprocal control matter. In a real cell, isocitrate and effectors would also change, so fixed-rate reasoning is only a diagnostic toy calculation.

Transcription changes the available capacities over longer times. The genes aceA and glcB encode isocitrate lyase and malate synthase. Promoter reporters, DNA-affinity capture and genetic perturbation implicated RccR in carbon-source-dependent repression of the shunt machinery.^[ref] A later study directly identified KDPG as an RccR ligand and linked RccR-dependent control of central carbon genes to aminoglycoside tolerance.^[ref] A metabolite-sensing transcription factor can therefore adjust enzyme supply according to carbon metabolism, while the already present enzymes remain subject to rapid regulation. Reporter expression must be normalized to biomass and growth state; increased luminescence does not directly measure flux.

The branchpoint is important during growth on acetate ion or fatty acids, which supply acetyl units without automatically replacing the four-carbon precursors withdrawn for biomass. The shunt enables net assimilation into gluconeogenic material. However, carbon conservation has a cost: bypassing oxidative steps changes the yield and distribution of reducing equivalents and metabolites such as alpha-ketoglutarate. An exclusive shunt would not meet every requirement of the cell. Flexible partitioning allows the bacterium to exploit changing nutrient mixtures and maintain biosynthetic and energetic demands together.

This flexibility can also influence infection-associated physiology. Changes in oxidative metabolism can alter respiration, proton-motive force and the physiological response to some antibiotics. A survival phenotype is not equivalent to a higher resistance-conferring target-mutation frequency, and an enzyme essential in one carbon source need not be essential in every infection niche. Compare carbon-defined cultures, measure growth and respiration, and test whether the same metabolic perturbation changes both flux and antibiotic killing. The RccR evidence supports a connection to tolerance in the tested conditions rather than a universal therapeutic prediction.

A rigorous test combines carbon-13 metabolic flux analysis, intracellular metabolite measurements, enzyme phosphorylation state and gene-expression measurements. Use individual and combined dehydrogenase perturbations, isocitrate-lyase controls and genetic rescue. Confirm that the flux model can distinguish the oxidative route from the shunt and account for other anaplerotic reactions. The branchpoint is a regulated allocation decision: allostery, ICD phosphorylation and metabolite-responsive transcription cooperate to conserve carbon when precursors are limiting and support oxidative metabolism when their supply permits it.

Hans Adolf Krebs described the experimental reasoning in his 1953 Nobel lecture. Pigeon breast skeletal muscle retained strong oxidative activity after preparation in a Latapie mincing mill and suspension in aqueous medium. Small fumarate additions increased oxygen uptake by more than complete oxidation of the added fumarate could explain; added four-carbon acids could still be detected afterward. His Table 1 compares the increase in uptake with that calculated from complete consumption of the addition. These comparisons challenge the interpretation that the addition merely supplied extra fuel.^[ref]

The lecture identifies the preparation apparatus but does not describe the gas-measuring instrument behind Table 1. The result supports regeneration, not a unique complete reaction mechanism. Its later discussion combines citrate formation from oxaloacetate with breakdown back toward the four-carbon intermediates to close the cycle. Competitive inhibition supplies another comparison: malonate inhibits succinate dehydrogenase, and succinate accumulates. Such evidence links a blocked step to the surrounding metabolic pathway; damaged tissue and restricted inhibitor access can complicate interpretation.^[ref]

An increase above the added fuel's own oxygen demand is a particularly revealing control on the explanation: it compares the proposed cause with the largest effect that simple consumption could produce. The modern mitochondrial oxygen electrode assay asks a different question about a prepared mitochondrion, testing respiratory control through ADP additions. Neither an oxygen uptake signal nor an accumulating intermediate is by itself a direct measurement of ATP production.